Collegium Pharmaceutical Stock News

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Incyte (INCY), SAGE Therapeutics (SAGE) and Pfenex (PFNX)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Incyte ( INCY – Research Report ), SAGE Therapeutics ( SAGE – Research Report ) and Pfenex ( PFNX �

The market remains unsettled but is moving higher as it expects good things to happen after the hot spots peak. The impact of the pandemic will keep expanding d

Goldman Sachs Group Inc. increased its stake in Collegium Pharmaceutical Inc (NASDAQ:COLL) by 204.0% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commi

Cubist Systematic Strategies LLC bought a new position in shares of Collegium Pharmaceutical Inc (NASDAQ:COLL) in the 4th quarter, according to its most recent filing with the Securities and Exchange

STOUGHTON, Mass., April 07, 2020 -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain.

Needham analyst Serge Belanger maintained a Buy rating on KalVista Pharmaceuticals (KALV) today and set a price target of $28.00. The company's shares

Needham analyst Serge Belanger maintained a Buy rating on KalVista Pharmaceuticals (KALV – Research Report) today and set a price

H.C. Wainwright analyst Oren Livnat maintained a Buy rating on Menlo Therapeutics (MNLO) today and set a price target of $2.00. The company's shares

H.C. Wainwright analyst Oren Livnat maintained a Buy rating on Menlo Therapeutics ( MNLO – Research Report ) today and set a price target of $2.00 . The company’s shares closed last Monday at $1.4

Collegium Pharmaceutical Inc (NASDAQ:COLL) shares shot up 8.9% on Monday . The stock traded as high as $17.74 and last traded at $17.56, 494,328 shares traded hands during mid-day trading. A decline o

Top Ranked Growth Stocks to Buy for April 6th

Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, April 6th

Franklin Resources Inc. lowered its stake in shares of Collegium Pharmaceutical Inc (NASDAQ:COLL) by 5.0% during the fourth quarter, HoldingsChannel.com reports. The firm owned 1,770,152 shares of the

Collegium Pharmaceutical Inc (NASDAQ:COLL) – Equities research analysts at Jefferies Financial Group reduced their FY2020 earnings per share (EPS) estimates for Collegium Pharmaceutical in a report